## **Trustees' Annual Report for the period** 

Period start date Period end date 01 APRIL 2024 31 MARCH 2025 **From To** 

## Section A                        Reference and administration details 

**Charity name**[The Ellie Mawdsley Foundation ] 

**Other names charity is known by** 

**Registered charity number (if any)** 1208055 

**Charity's principal address** 

100a Blundells Lane 

Rainhill Merseyside **Postcode L35 6NB** 

## **Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year **|**Name of person (or body) entitled**<br>**to appoint trustee (ifany)**|
|---|---|---|---|---|
||Karen Mawdsley|Chair|||
||Ian Mawdsley||||
||Jack Foley||||
||Jonathan Ford||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||
||||||



**Names of the trustees for the charity, if any, (for example, any custodian trustees)** 

**Name Dates acted if not for whole year** 

March **2012** 

**TAR** 

1 



|**Names and addresses of advisers (Optional information)**<br>**Type of adviser**<br>**Name**<br>**Address**|**Names and addresses of advisers (Optional information)**<br>**Type of adviser**<br>**Name**<br>**Address**|**Names and addresses of advisers (Optional information)**<br>**Type of adviser**<br>**Name**<br>**Address**|
|---|---|---|
||||
||||
||||
||||



**Name of chief executive or names of senior staff members (Optional information)** 

## **Section B              Structure, governance and management** 

## **Description of the charity’s trusts** 

Type of governing document 

Constitution 

- (eg. trust deed, constitution) 

Charitable Incorporated Organisation How the charity is constituted 

- (eg. trust, association, company) 

Appointed by trustees Trustee selection methods 

- (eg. appointed by, elected by) 

## **Additional governance issues (Optional information)** 

You **may choose** to include additional information, where relevant, about: 

- policies and procedures adopted for the induction and training of trustees; 

- the charity’s organisational structure and any wider network with which the charity works; 

- relationship with any related parties; 

- trustees’ consideration of major risks and the system and procedures to manage them. 

## **Section C                    Objectives and activities** 

**Summary of the objects of the charity set out in its governing document** 

(1) To relieve sickness and to preserve the health of sufferers of cancer and brain tumour by providing or assisting in the provision of equipment, medication, facilities and services. (2) To promote research for the public benefit into the causes and the treatment of brain tumour, in particular diffuse intrinsic pontine glioma (DIPG) and to disseminate the useful results of such research. 

March **2012** 

**TAR** 

2 



To support the relief of sickness and preservation of health, the charity provides or assists in the provision of equipment, medication, facilities and services intended to improve the wellbeing, comfort and treatment experience of people affected by cancer and brain tumours. This support may be delivered directly or through grants to hospitals, hospices, support organisations and other appropriate bodies working with patients and families. Where relevant, support may also extend to families and carers where this contributes to improved outcomes or wellbeing for the person affected. 

**Summary of the main activities undertaken for the public benefit in relation to these objects (include within this section the statutory declaration that trustees have had regard to the guidance issued by the Charity Commission on public benefit)** 

To promote research for the public benefit, the charity supports and funds research projects focused on improving understanding, diagnosis and treatment of brain tumours, particularly DIPG. The charity works with established research institutions, clinicians and research organisations to ensure that supported research is credible, ethically governed and capable of delivering meaningful public benefit. The charity seeks to ensure that the useful results of research it supports are disseminated appropriately, so that knowledge gained can benefit patients, clinicians, researchers and the wider public. 

In carrying out these activities, the trustees aim to ensure that support is directed towards genuine need, that any private benefit is incidental and proportionate, and that activities are aligned with the charity’s objects. 

The trustees have had due regard to the Charity Commission’s guidance on public benefit when exercising their powers and duties and when planning and reviewing the charity’s activities. 

## **Additional details of objectives and activities (Optional information)** 

You **may choose** to include further statements, where relevant, about: 

- policy on grantmaking; 

- policy programme related investment; 

- contribution made by volunteers. 

March **2012** 

**TAR** 

3 



Section D                      Achievements and performance 

**Summary of the main achievements of the charity during the year** 

During the year The Ellie Mawdsley Foundation carried out a range of fund raising activities, these included the delivery of Christmas Wreath Workshops, a Fine Dining evening and a Charity Ball.  In addition, funds were raised through participants taking part in organised running events. As a result of these collective fundraising efforts, The Ellie Mawdsley Foundation has been able to support a meaningful project. This project offers patients diagnosed with a brain tumour the opportunity to experience a special event or activity of their choice, helping to create memorable moments during a challenging time. 

March **2012** 

**TAR** 

4 



## **Section E                    Financial review** 

## **Brief statement of the** 

The charity aims to hold minimal reserves, sufficient for 6–12 months of basic operating costs. This is estimated at £2,500. 

**charity’s policy on reserves** 

**Details of any funds materially in deficit** 

None 

## **Further financial review details (Optional information)** 

You **may choose** to include additional information, where relevant about: 

- the charity’s principal sources of funds (including any fundraising); 

- how expenditure has supported the key objectives of the charity; 

- investment policy and objectives including any ethical investment policy adopted. 

## **Section F                     Other optional information** 

## **Section G                    Declaration** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

## **Signature(s)** 


**Full name(s)** Karen Mawdsley **Position (eg Secretary, Chair,** Chair **etc)** 

**Date** 13 January 2026 

March **2012** 

**TAR** 

5 



**The Ellie Mawdsley Foundation** 


**1208055** 

## **Receipts and payments accounts** 

## **CC16a** 

|**For the period**<br>**from**|01/04/2024|**To**|31/03/2025|
|---|---|---|---|



## **Section A Receipts and payments** 

|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest      £**|**Unrestricted**<br>**funds**<br>**to the nearest      £**|**Restricted funds**<br>**to the nearest £**|**Restricted funds**<br>**to the nearest £**|**Endowment**<br>**funds**<br>**to the nearest £**|**Endowment**<br>**funds**<br>**to the nearest £**|**Total funds**<br>**to the nearest £**|**Total funds**<br>**to the nearest £**|**Last year**<br>**to the nearest £**|
|---|---|---|---|---|---|---|---|---|---|
|<br>Donations|**118,117**||**-**||**-**||**118,117**||**-**|
|Other tradingactivities|**17,476**||**-**||**-**||**17,476**||**-**|
|Bank interest|**771**||**-**||**-**||**771**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
|**_Sub total_**_(Gross income for AR)_|**136,364**||**-**||**-**||**136,364**||**-**|
|||||||||||
|**A2 Asset and investment sales,**<br>**(see table).**||||||||||
||**-**|||||||||
||**-**||||||||**-**|
|**_Sub total_**|**-**||||||||**-**|
|**_Total receipts_**<br>**A3 Payments**||||||||||
||||||||||**-**|
|||||||||||
|<br>Direct expenses|**309**||**-**||**-**||**309**||**-**|
|Event costs|**4,018**||**-**||**-**||**4,018**||**-**|
|Advertisingand marketing|**2,609**||**-**||**-**||**2,609**||**-**|
|Bank charges|**37**||**-**||**-**||**37**||**-**|
|Donations|**5,001**||**-**||**-**||**5,001**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
||**-**||**-**||**-**||**-**||**-**|
|**_Sub total_ **|**11,974**||**-**||**-**||**11,974**||**-**|
|||||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**||||||||||
||**-**|||||||||
||**-**|||||||||
|**_Sub total_ **|**-**||||||||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**||||||||||
||||||||||**-**|
|||||||||||
||**124,390**||||||||**-**|
||**-**||||||||**-**|
||**-**||||||||**-**|
||**124,390**||||||||**-**|



## **Section B Statement of assets and liabilities at the end of the period** 

|CCXX R1 accounts (SS)<br>**Categories**<br>**B1 Cash funds**|1<br>Allica Current account<br>Allica Savings account<br>Metrobank<br>**Details**<br>**_Total cash funds_**|**Unrestricted**<br>**funds**<br>**271**<br>**271**<br>**85,500**<br>**38,619**<br>**124,390**|**Restricted funds**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|---|
|||**271**|**-**|**-**|
|||**85,500**|**-**|**-**|
|||**38,619**|**-**|**-**|
|||**124,390**|**-**|22/01/2026<br>**-**|



CCXX R1 accounts (SS) 



|Signed by one or two trustees on<br>behalf of all the trustees<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B5 Liabilities**<br>**B3 Investment assets**|Signature<br>**Details**<br>**Details**<br>**Details**<br>(agree balances with receipts and payments account(s))<br>**Details**|OK<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which asset**<br>**belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which asset**<br>**belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Jonathan Ford|OK|
|---|---|---|---|
||||**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of approval|
||||**16/12/2025**|
|||||



CCXX R2 accounts (SS) 

22/01/2026 

2 



J£J

1111
1111
111
QO ThOfflJll WllWll

lllllll
111111111
111111111
111111
111111
111111
11111
11111
11111